Jonathan E. Shoag

4.4k total citations · 1 hit paper
121 papers, 2.5k citations indexed

About

Jonathan E. Shoag is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Jonathan E. Shoag has authored 121 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 35 papers in Surgery and 27 papers in Oncology. Recurrent topics in Jonathan E. Shoag's work include Prostate Cancer Diagnosis and Treatment (57 papers), Prostate Cancer Treatment and Research (35 papers) and Bladder and Urothelial Cancer Treatments (24 papers). Jonathan E. Shoag is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (57 papers), Prostate Cancer Treatment and Research (35 papers) and Bladder and Urothelial Cancer Treatments (24 papers). Jonathan E. Shoag collaborates with scholars based in United States, Canada and South Africa. Jonathan E. Shoag's co-authors include Zoltàn Arany, Jim C. Hu, Glenn C. Rowe, Joshua A. Halpern, Rizwan Haq, David E. Fisher, Jun S. Song, Satoru Yokoyama, Dennie T. Frederick and Abhinav Nellore and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Jonathan E. Shoag

112 papers receiving 2.5k citations

Hit Papers

Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α a... 2013 2026 2017 2021 2013 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan E. Shoag United States 24 906 905 472 410 365 121 2.5k
Nobumichi Tanaka Japan 29 1.3k 1.4× 656 0.7× 649 1.4× 314 0.8× 204 0.6× 248 3.0k
Mansoor M. Ahmed United States 35 1.1k 1.2× 1.1k 1.2× 985 2.1× 454 1.1× 111 0.3× 116 3.5k
Winston Tan United States 27 1.1k 1.2× 873 1.0× 1.4k 3.0× 690 1.7× 416 1.1× 117 3.6k
Xiaodong He China 28 516 0.6× 1.0k 1.1× 660 1.4× 600 1.5× 118 0.3× 225 2.8k
Alice Huertas France 30 2.4k 2.6× 814 0.9× 234 0.5× 299 0.7× 286 0.8× 66 3.2k
Ana Barac United States 38 658 0.7× 850 0.9× 1.6k 3.4× 331 0.8× 247 0.7× 157 4.8k
Shiying Yu China 31 926 1.0× 1.5k 1.7× 1.3k 2.8× 870 2.1× 496 1.4× 141 3.7k
Hayato Yamamoto Japan 26 738 0.8× 610 0.7× 387 0.8× 169 0.4× 130 0.4× 196 2.5k
Takuya Koie Japan 28 1.2k 1.3× 876 1.0× 507 1.1× 278 0.7× 95 0.3× 316 3.2k
Aurelius Omlin Switzerland 32 1.9k 2.1× 816 0.9× 1.3k 2.8× 985 2.4× 368 1.0× 115 3.6k

Countries citing papers authored by Jonathan E. Shoag

Since Specialization
Citations

This map shows the geographic impact of Jonathan E. Shoag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan E. Shoag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan E. Shoag more than expected).

Fields of papers citing papers by Jonathan E. Shoag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan E. Shoag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan E. Shoag. The network helps show where Jonathan E. Shoag may publish in the future.

Co-authorship network of co-authors of Jonathan E. Shoag

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan E. Shoag. A scholar is included among the top collaborators of Jonathan E. Shoag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan E. Shoag. Jonathan E. Shoag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jang, Albert, Prateek Jain, Adam Calaway, et al.. (2025). Advanced urothelial carcinoma treated with enfortumab vedotin and pembrolizumab: a path to cure?. The Oncologist. 30(9).
2.
Lewicki, Patrick, et al.. (2024). ADOPTION, COST, AND THE ECONLY OF SCALE OF ROBOTIC VERSUS LAPAROSCOPIC RADICAL NEPHRECTOMY PROCEDURES. Urologic Oncology Seminars and Original Investigations. 42. S39–S39. 1 indexed citations
3.
Greenberg, Daniel R., Hriday P. Bhambhvani, Hiten D. Patel, et al.. (2024). Hypogonadism, frailty, and postoperative outcomes among men undergoing radical nephrectomy. Journal of Surgical Oncology. 129(7). 1341–1347. 1 indexed citations
4.
Brant, Aaron, et al.. (2024). Trends in hospital price transparency after implementation of the CMS Final Rule. Health Services Research. 59(4). e14329–e14329. 2 indexed citations
5.
Brant, Aaron, et al.. (2023). Price transparency of prostate cancer care in the United States: An analysis of pricing and disclosure following the centers for medicare and medicaid mandate. Prostate Cancer and Prostatic Diseases. 27(2). 252–256. 3 indexed citations
6.
Rhodes, Stephen, Weichuan Dong, Johnie Rose, et al.. (2023). Individual-level home values and cancer mortality in a statewide registry. JNCI Cancer Spectrum. 7(6).
7.
Brant, Aaron, et al.. (2023). Insurer coverage of prostate cancer biomarkers. Urologic Oncology Seminars and Original Investigations. 41(7). 324.e9–324.e12.
8.
Hu, Jim C., Andrew J. Vickers, Mohamad E. Allaf, et al.. (2023). Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplications. BMJ Open. 13(5). e071191–e071191. 2 indexed citations
9.
Vince, Randy, Merrick Bank, Yilun Sun, et al.. (2023). Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients. JAMA Network Open. 6(1). e2250416–e2250416. 46 indexed citations
10.
Brant, Aaron, Patrick Lewicki, Nahid Punjani, et al.. (2022). Trends in Antimicrobial Prophylaxis for Inflatable Penile Prosthesis Surgery From a Large National Cohort. Urology. 172. 131–137. 1 indexed citations
11.
Brant, Aaron, Patrick Lewicki, Christina Sze, et al.. (2022). Impact of Left-Digit Age Bias in the Treatment of Localized Prostate Cancer. The Journal of Urology. 208(5). 997–1006. 3 indexed citations
12.
Lewicki, Patrick, Spyridon P. Basourakos, Randy Vince, et al.. (2022). Race and prostate cancer: genomic landscape. Nature Reviews Urology. 19(9). 547–561. 22 indexed citations
13.
Liu, Deli, Michael A. Augello, Ivana Grbeša, et al.. (2021). Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer. Journal of Clinical Investigation. 131(10). 27 indexed citations
14.
Gupta, Karishma, et al.. (2021). Temporal improvements in renal surgery outcomes across surgical approaches. International Urology and Nephrology. 53(7). 1311–1316. 2 indexed citations
15.
Sholle, Evan, Prakash Adekkanattu, Marika Cusick, et al.. (2021). Automated Extraction of Tumor Staging and Diagnosis Information From Surgical Pathology Reports. JCO Clinical Cancer Informatics. 5(5). 1054–1061. 13 indexed citations
16.
Basourakos, Spyridon P., Keith Kowalczyk, Márcio Covas Moschovas, et al.. (2021). Robot-Assisted Radical Prostatectomy Maneuvers to Attenuate Erectile Dysfunction: Technical Description and Video Compilation. Journal of Endourology. 35(11). 1601–1609. 19 indexed citations
17.
Shoag, Jonathan E., Paul J. Christos, Sameer Mittal, et al.. (2017). Vasectomy and Risk of Prostate Cancer in a Screening Trial. Cancer Epidemiology Biomarkers & Prevention. 26(11). 1653–1659. 10 indexed citations
18.
Shoag, Jonathan E. & Brian H. Eisner. (2013). Relationship between C-reactive Protein and Kidney Stone Prevalence. The Journal of Urology. 191(2). 372–375. 30 indexed citations
19.
Ruas, Jorge L., Rana K. Gupta, Robyn P. Thom, et al.. (2009). The transcriptional coactivator PGC-1α mediates exercise-induced angiogenesis in skeletal muscle. Proceedings of the National Academy of Sciences. 106(50). 21401–21406. 312 indexed citations
20.
Kambayashi, Taku, Eric J. Allenspach, John T. Chang, et al.. (2009). Inducible MHC Class II Expression by Mast Cells Supports Effector and Regulatory T Cell Activation. The Journal of Immunology. 182(8). 4686–4695. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026